News
GNCAQ
0.0001
NaN%
--
Weekly Report: what happened at GNCAQ last week (0401-0405)?
Weekly Report · 5d ago
Weekly Report: what happened at GNCAQ last week (0325-0329)?
Weekly Report · 04/01 10:39
Weekly Report: what happened at GNCAQ last week (0318-0322)?
Weekly Report · 03/25 10:41
Weekly Report: what happened at GNCAQ last week (0311-0315)?
Weekly Report · 03/18 10:40
Weekly Report: what happened at GNCAQ last week (0304-0308)?
Weekly Report · 03/11 10:38
Weekly Report: what happened at GNCAQ last week (0226-0301)?
Weekly Report · 03/04 10:40
Weekly Report: what happened at GNCAQ last week (0219-0223)?
Weekly Report · 02/26 10:49
Weekly Report: what happened at GNCAQ last week (0212-0216)?
Weekly Report · 02/19 10:51
Weekly Report: what happened at GNCAQ last week (0205-0209)?
Weekly Report · 02/12 10:43
Weekly Report: what happened at GNCAQ last week (0129-0202)?
Weekly Report · 02/05 10:49
Weekly Report: what happened at GNCAQ last week (0122-0126)?
Weekly Report · 01/29 10:41
Weekly Report: what happened at GNCAQ last week (0115-0119)?
Weekly Report · 01/22 10:44
Weekly Report: what happened at GNCAQ last week (0108-0112)?
Weekly Report · 01/15 10:41
Weekly Report: what happened at GNCAQ last week (0101-0105)?
Weekly Report · 01/08 10:44
Weekly Report: what happened at GNCAQ last week (1225-1229)?
Weekly Report · 01/01 10:40
Weekly Report: what happened at GNCAQ last week (1218-1222)?
Weekly Report · 12/25/2023 10:49
Weekly Report: what happened at GNCAQ last week (1211-1215)?
Weekly Report · 12/18/2023 10:53
Weekly Report: what happened at GNCAQ last week (1204-1208)?
Weekly Report · 12/11/2023 10:49
Weekly Report: what happened at GNCAQ last week (1127-1201)?
Weekly Report · 12/04/2023 10:49
Weekly Report: what happened at GNCAQ last week (1120-1124)?
Weekly Report · 11/27/2023 10:44
More
Webull provides a variety of real-time GNCAQ stock news. You can receive the latest news about Genocea Biosciences Inc through multiple platforms. This information may help you make smarter investment decisions.
About GNCAQ
Genocea Biosciences, Inc. is a biopharmaceutical company that is engaged in discovering and developing cancer immunotherapies using its Antigen Lead Acquisition System (ATLAS) technology platform. The Company’s Antigen Lead Acquisition System (ATLAS) technology platform allows to identify targets based on each person’s tumor antigen-specific T cell responses. Its programs include GEN-009 is a neoantigen vaccine candidate delivering adjuvanted synthetic long peptides spanning ATLAS-identified anti-tumor neoantigens. Its GEN-011 program is an adoptive T cell therapy using neoantigen-targeted peripheral T cells (NPTs). The GEN-011 NPTs is preferred for ATLAS-identified anti-tumor antigens that are used to manufacture a peripheral blood-derived, tumor-specific T cell therapy.